Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG
RA Capital Healthcare Fund LP bought 51,258 Hemab Therapeutics Holdings, Inc. shares (Form 4)
Traded May 7 to May 11, 2026 · Filed May 11, 2026
From May 7 to May 11, 2026, RA Capital Healthcare Fund LP (10% owner) bought 51,258 Hemab Therapeutics Holdings, Inc. shares at an average US$24.75 for US$1.27M, leaving 6,365,783 shares. Filed May 11, 2026 (Form 4).
- Bought
- 51,258 shares
- Price
- US$24.75 average (US$24.34 to US$25.00)
- Value
- US$1.27M
- Holding after
- 6,365,783 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock | Buy | 7,921 | US$24.34 | 6,322,446 | Indirect |
| May 7, 2026 | Common Stock | Buy | 1,985 | US$24.95 | 6,324,431 | Indirect |
| May 8, 2026 | Common Stock | Buy | 1,483 | US$24.98 | 6,325,914 | Indirect |
| May 11, 2026 | Common Stock | Buy | 14,149 | US$24.47 | 6,340,063 | Indirect |
| May 11, 2026 | Common Stock | Buy | 25,720 | US$25.00 | 6,365,783 | Indirect |
Source
Related
- Hemab Therapeutics Holdings, Inc.
- RA Capital Healthcare Fund LP
- Hemab Therapeutics Holdings, Inc. shareholders
- Schedule 13G · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Capital International Investors · Aug 12, 2026
- Schedule 13G · Invus Public Equities, L.P. · Aug 7, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026